Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Candidemia in immunocompromised patients.

F Meunier1, M Aoun, N Bitar

  • 1Service de Médecine Interne et Laboratoire d'Investigation Clinique Henri Tagnon, Centre des Tumeurs de l'Université Libre de Bruxelles, Belgium.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|March 1, 1992
PubMed
Summary

Non-albicans Candida species cause half of all fungemia cases. Patient outcomes for fungemia were similar regardless of the number of positive blood cultures or neutropenia status.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Steatotic liver disease is a marker of multimorbidity, not underlying cirrhosis, in older adults.

Npj gut and liver·2025
Same author

Dietary inclusion of hay of greater digestibility and water-soluble carbohydrate content increases performance of dairy cows, irrespective of concentrate type and breed.

Animal : an international journal of animal bioscience·2025
Same author

ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer.

ESMO open·2024
Same author

Determination of Escherichia coli phylogroups in elderly patients with urinary tract infection or asymptomatic bacteriuria.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Clinical efficacy of caspofungin in the treatment of invasive aspergillosis.

Medical mycology·2018
Same author

XAS/DRIFTS/MS spectroscopy for time-resolved operando investigations at high temperature.

Journal of synchrotron radiation·2018

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Hematology

Background:

  • Fungemia, a serious bloodstream infection, is often caused by Candida species.
  • Non-albicans Candida species are increasingly recognized as significant pathogens.

Purpose of the Study:

  • To analyze the prevalence of different Candida species in fungemia.
  • To investigate the association between Candida species and underlying malignancy.
  • To evaluate prognostic factors and treatment outcomes in fungemia patients.

Main Methods:

  • Retrospective analysis of patient data with fungemia.
  • Categorization of Candida species and correlation with patient diagnoses (solid tumors vs. hematologic malignancy).
  • Comparison of mortality rates based on number of positive blood cultures, neutropenia, and treatment regimens.

Related Experiment Videos

Main Results:

  • Non-albicans Candida species accounted for 50% of fungemia cases.
  • Specific Candida species showed differential prevalence in solid tumor versus hematologic malignancy patients (P = .001).
  • Mortality rate was 41.8%, lower than previously reported; no significant difference in outcomes between single or multiple positive blood cultures.
  • No significant difference in mortality between amphotericin B and fluconazole treatments.
  • Disseminated candidiasis was more common in neutropenic patients (P = .03).

Conclusions:

  • Non-albicans Candida species are a major cause of fungemia, with species distribution linked to malignancy type.
  • Prognosis is not significantly affected by the number of positive cultures.
  • Current antifungal treatments show comparable outcomes in this retrospective study.
  • Neutropenia increases the risk of disseminated candidiasis.